VITROSCAN
VitroScan is a Dutch biotech company founded in 2016 and based at the Leiden Bio Science Park. We develop certified predictive ex vivo 3D tumor testing services for reliable treatment response prediction for the clinic and to improve patient stratification for clinical trials. Our proprietary technology provides highly reproducible drug testing in the native tumor microenvironment (TME). VitroScan’s clinical trial program is performed in collaboration with expert clinicians from leading oncol... ogy centers. In these trials patient specific ex vivo tumor sensitivity to chemo-, targeted, or immunotherapy is correlated to clinical outcomes. We are dedicated to delivering predictive diagnostic testing to support better informed treatment decisions for cancer patients. Explore our website to learn more www.vitroscan.nl
VITROSCAN
Industry:
Bioinformatics Biopharma Biotechnology Clinical Trials Health Care Information Technology Life Science
Founded:
2016-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.vitroscan.nl
Total Employee:
1+
Status:
Active
Contact:
+31 71 3322 866
Total Funding:
800 K EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Tag Manager LetsEncrypt SSL By Default HSTS ReCAPTCHA Nginx
Similar Organizations
Alcuris
Alcuris designs and manufactures a connectivity device to support the independence of older individuals.
Cellexus
Revolutionary single use bioreactor systems
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Design Research Lab
Design Research Lab develops interdisciplinary design research projects focused on four areas.
Ebba Biotech AB
Ebba Biotech AB specializes in amyloid dyes, neurodegenerative diseases, renewable biomaterials, biofilm, and infection diagnostics.
Epithelix
Epithelix SÃ rl, provides alternative in vitro solutions to animal experimentation
Fen EP Limited
Fen EP Limited is a developer of biomedical device created to prevent sudden cardiac death.
SYDRA
AI-assisted novel geroprotectors discovery and in vivo testing. Translation into longevity supplements and anti-aging drugs.
Trialize
Automating clinical trials with AI and RPA
Current Employees Featured
Willemijn Vader CEO @ VitroScan
CEO
2016-01-01
Founder
Official Site Inspections
http://www.vitroscan.nl
- Host name: vps15.websteen.nl
- IP address: 178.22.62.95
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "VitroScan"
Predicting Treatment Outcome | VitroScan
VitroScan develops predictive testing solutions to support better informed treatment decisions for cancer patients. Our ex vivo drug response platform is proven effective for identifying and …See details»
Company | VitroScan
We support personalized treatment strategies by identifying effective therapies for patients while reducing the toxicity and cost of inefficacious treatments at the …See details»
Patients and Doctors | VitroScan
VitroScan develops ex vivo tumor testing to support better informed treatment decisions for cancer patients. We collaborate with clinical experts to validate and implement our solutions in …See details»
VitroScan - Crunchbase Company Profile & Funding
VitroScan is a Dutch biotech company founded in 2016 and based at the Leiden Bio Science Park. We develop certified predictive ex vivo 3D tumor testing …See details»
VitroScan - LinkedIn
VitroScan is a Dutch biotech company founded in 2016 and based at the Leiden Bio Science Park. We develop certified predictive ex vivo 3D tumor testing services for reliable treatment...See details»
VitroScan Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for VitroScan. Use the PitchBook Platform to explore the full profile.See details»
VitroScan - Overview, News & Similar companies | ZoomInfo.com
VitroScan B.V. is a Dutch biotech company based at the Leiden Bio Science Park. The company was founded in September 2016 as a spin-off company fro m OcellO, and has a license to the …See details»
VitroScan B.V. - Leiden Bio Science Park
Housing over 215 organisations, including 150 Life Sciences & Health (LSH) companies – from start-ups to multinationals – and several internationally acclaimed research institutes, the …See details»
Contact | VitroScan
We're here to listen to your tumor testing challenges, questions and plans and to co-develop a solution that fits your specifications. Please leave your details and message in the form below …See details»
VitroScan profiles - FinalScout
VitroScan is a Dutch biotech company founded in 2016 and based at the Leiden Bio Science Park. We develop certified predictive ex vivo 3D tumor testing services for reliable treatment …See details»
VitroScan - Company Profile - Tracxn
3 days ago · Provider of a diagnostic platform for precision treatments for cancer patients. The company offers a 3D drug response platform that helps in predicting the drug reactions on the …See details»
InCephalo AG, University of Basel and VitroScan win ... - LinkedIn
Oct 9, 2023 · VitroScan is a Dutch biotech company founded in 2016 and based at the Leiden Bio Science Park. The company develops fast and accurate predictive testing solutions for …See details»
Vitroscan - Products, Competitors, Financials, Employees, …
VitroScan is a biotech company focused on providing predictive testing solutions for cancer treatment selection. Use the CB Insights Platform to explore Vitroscan's full profile.See details»
Biopharma Services - VitroScan
VitroScan offers services to support efficient and successful drug development by near clinical testing. Typical projects combine ex vivo 3D micro tumor testing using patient derived tumor …See details»
Press Release - VitroScan closes €800k seed funding round
Apr 11, 2019 · Leiden, The Netherlands, April 11, 2019 – VitroScan, developing tests to predict treatment outcome for cancer patients, has closed a round of seed funding for €800.000. Lead …See details»
VitroScan closes funding round - hollandbio
Apr 11, 2019 · VitroScan, developing tests to predict treatment outcome for cancer patients, has closed a round of seed funding for €800.000. Lead investor Libertatis Ergo Holding B.V. (LEH) …See details»
Innovations in Personalized Oncology: Advanced Healthcare …
Oct 20, 2023 · VitroScan is making strides in the In Vitro Diagnostic Innovation. Their unique ex vivo platform for tumor testing tests tumor tissue from patients. It exposes cancer tissues to …See details»
Our Team | VitroScan
The VitroScan team consists of highly motivated experts in life science business, oncology, cell biology, bioinformatics, and clinical trials. We aim to support personalized treatment strategies …See details»
VitroScan ontvangt 1,9 miljoen euro van Biotech Booster - PLNT
3 days ago · VitroScan biedt voorspellende testoplossingen gebaseerd op ex vivo 3D microtumor testen. Recente gegevens hebben een sterke correlatie tussen de testresultaten en de …See details»
VitroScan's copany video | VitroScan
For the past year, VitroScan has been collaborating with nine exceptional Leiden-based startups as a part of the Leiden Bio Science Park Startup Booster project. Now, we're thrilled to …See details»